BME 695N Lecture 20: GMP and issues of quality control manufacture of nanodelivery systems episode artwork

EPISODE · Nov 15, 2007

BME 695N Lecture 20: GMP and issues of quality control manufacture of nanodelivery systems

from [Audio] BME 695N: Engineering Nanomedical Systems (Fall 2007) · host James Leary

Outline:Overview What does cGMP mean? Why GMP? Controlling processes means more predictable outcomes… Enforcement What can be learned from the semi-conductor industry clean-room and manufacturing? What doesn’t fit this paradigm?cGMP-level manufacturing Predictable methods lead to predictable products The CFR (Code of Federal Regulations) sections on GMPs What is covered under cGMP?Bionanomanufacturing So what is special about biomanufacturing? Nano-clean water necessary for nano-pharmaceuticals Contaminants at the nano-level Can you scale up the process?Some quality control issues – how to test Correctness of size – size matters! Composition – atomic level analyses Monodispersity versus agglomeration Order and correctness of layers Correctness of zeta potentials Does the nanomedical system contain the correct payload? Targeting (and mis-targeting) specificity and sensitivity

Episode metadata supplied by the publisher feed · Published Nov 15, 2007

Embed this episode

NOW PLAYING

BME 695N Lecture 20: GMP and issues of quality control manufacture of nanodelivery systems

0:00 0:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

When was this [Audio] BME 695N: Engineering Nanomedical Systems (Fall 2007) episode published?

This episode was published on November 15, 2007.

Can I download this [Audio] BME 695N: Engineering Nanomedical Systems (Fall 2007) episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!